The Chairman's Corner

Using insurance (claims) data for drug development


Chinese Course on Drug Development and Regulatory Science

Once approved, an evergreen? Drug manufacturers are facing challenges when it comes to their drugs. Not only competing drugs but also real world data continuously question approved drugs in terms of efficacy, efficiency, adverse events and polymedication. Insurance claims data, as a fantastic form of real world data, therefore create an opportunity for manufacturers and their research institutes in positioning innovation longterm. Payors and pharma should team-up.

Presentation (PDF, 2MB)